Coronavirus Vaccine Research at Valneva SA Labs

A lab technician wearing a full body protection suit handles a bottle containing growth media for virus production during coronavirus vaccine research at the Valneva SA laboratories in Vienna, Austria, on Thursday, Aug. 6, 2020. The U.K. has signed agreements to buy 90 million doses of vaccines in development by drugmakers including Pfizer Inc., BioNTech SE and Valneva SE, joining countries around the world racing to secure supplies of protection against Covid-19. Photographer: Akos Stiller/Bloomberg via Getty Images
A lab technician wearing a full body protection suit handles a bottle containing growth media for virus production during coronavirus vaccine research at the Valneva SA laboratories in Vienna, Austria, on Thursday, Aug. 6, 2020. The U.K. has signed agreements to buy 90 million doses of vaccines in development by drugmakers including Pfizer Inc., BioNTech SE and Valneva SE, joining countries around the world racing to secure supplies of protection against Covid-19. Photographer: Akos Stiller/Bloomberg via Getty Images
Coronavirus Vaccine Research at Valneva SA Labs
PURCHASE A LICENSE
How can I use this image?
€475.00
EUR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
1227935166
Collection:
Bloomberg
Date created:
August 06, 2020
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
AUSTRIA VALNEVA
Max file size:
4000 x 2667 px (13.33 x 8.89 in) - 300 dpi - 5 MB